Healthcare and Medical Devices: AI Market Discovery Index
Tracking how AI platforms recommend healthcare and medical devices. This public AI Market Discovery Index is updated monthly since July 2026.

On this page
- 01Benchmark Summary
- 02Current Benchmark at a Glance
- 03Research Scope and Qualification
- 04Current Brand Standings
- 05How to Read the Standings
- 06Recommendation Coverage Movement
- 07Largest Increase: Prodigy Diabetes Care
- 08Category Leader: Abbott FreeStyle
- 09Recommendation Placement Snapshot
- 10Buyer-Intent Distribution
- 11Historical Measurement Record
- 12Evidence and Source Layer
Benchmark Summary
Abbott FreeStyle led the Healthcare and Medical Devices benchmark in August 2026 with a valid recommendation coverage of 61.6%, up from 55.6% in July 2026. The gap to the next brand, Ascensia CONTOUR at 41.0% in August 2026, widened to 20.6 points from 15.5 points in July 2026.
Prodigy Diabetes Care recorded the largest coverage increase, rising to 3.0% in August 2026 from 0.9% in July 2026. No brand recorded a significant coverage decline during the month.
Across the full July-to-August series, Abbott FreeStyle climbed 6.0 points, Ascensia CONTOUR rose 0.9 points, LifeScan OneTouch gained 0.6 points, Roche Accu-Chek increased 2.5 points, and Trividia Health edged down 0.3 points. Prodigy Diabetes Care posted the only movement classified as beyond normal month-to-month variation.
The benchmark began with 645 prompt-surface observations in August 2026 and produced 393 qualified observations after qualification.
AI recommendation trend
valid recommendation coverage, Jul 2026 to Aug 2026
- Abbott FreeStyle+6.0%Jul 202655.6%Aug 202661.6%
- Ascensia CONTOUR+0.9%Jul 202640.1%Aug 202641.0%
- Roche Accu-Chek+2.5%Jul 202628.5%Aug 202631.0%
- LifeScan OneTouch+0.6%Jul 202610.9%Aug 202611.5%
- Prodigy Diabetes Care+2.1% · beyond normal variationJul 20260.9%Aug 20263.0%
- Trividia Health-0.3%Jul 20260.5%Aug 20260.2%
Current Benchmark at a Glance
Measure | Jul 2026 | Aug 2026 | Movement |
|---|---|---|---|
Qualified benchmark observations | 432 | 393 | Down 39 |
Tracked brands | 6 | 6 | No change |
Qualified surface breadth | 6 | 6 | No change |
Recommendation-shaped answer share | 30.8% | 36.9% | Up 6.1 points |
Valid recommendation shortlist share | 56.5% | 57.5% | Up 1.0 points |
Leader by valid recommendation coverage | Abbott FreeStyle (55.6%) | Abbott FreeStyle (61.6%) | Up 6.0 points |
Qualified surface breadth counts the six canonical AI/search surface families with at least one qualified observation: ChatGPT, Copilot, Gemini, Perplexity, AI Overviews, and AI Mode. All six families were represented in both months.
For the strategic interpretation of this benchmark, read CiteWorks Studio's analysis of How AI Search Is Recommending Healthcare and Medical Devices
Research Scope and Qualification
The public benchmark is narrower than the raw collection universe by design.
Research stage | Jul 2026 | Aug 2026 | What it represents |
|---|---|---|---|
Source prompt-surface observations | 657 | 645 | Total prompt-surface observations collected |
Unique questions | 469 | 486 | Distinct questions asked |
Brand / competitor mentions | 657 | 645 | Prompts mentioning at least one tracked brand |
Relevant observations | 648 | 637 | Observations relevant to the vertical |
Irrelevant observations | 9 | 8 | Observations outside the research scope |
Qualified benchmark observations | 432 | 393 | Public denominator for brand metrics |
Brand-level percentages use the qualified observations as the public denominator, not the raw collection. AI Market Discovery Methodology
Want the full Authority Index
The paid deep-dive adds competitor threat profiles, the gap matrix, citation failure map, platform-by-platform recovery roadmap, and client-specific economic modeling.
Current Brand Standings
Brand | Presence rate | Valid recommendation coverage | Top-three rate | Rank-one rate | Net sentiment |
|---|---|---|---|---|---|
Abbott FreeStyle | 95.2% | 61.6% | 53.2% | 9.7% | 0.8 |
Ascensia CONTOUR | 49.1% | 41.0% | 37.1% | 28.5% | 0.9 |
Roche Accu-Chek | 37.7% | 31.0% | 24.2% | 2.5% | 0.9 |
LifeScan OneTouch | 19.9% | 11.5% | 7.6% | 0.2% | 0.7 |
Prodigy Diabetes Care | 3.6% | 3.0% | 2.5% | 0.0% | 0.9 |
Trividia Health | 1.3% | 0.2% | 0.2% | 0.0% | 0.6 |
How to Read the Standings
- Presence rate: share of qualified observations where the brand is mentioned at all.
- Valid recommendation coverage: share of qualified observations where the brand appears in a valid recommendation shortlist.
- Top-three rate: share of qualified observations where the brand appears in the top three recommended positions.
- Rank-one rate: share of qualified observations where the brand is the first recommendation.
- Net sentiment: positive minus negative mention sentiment, scaled.
For formulas and denominator rules, see AI Market Discovery Metric Definitions.
Recommendation Coverage Movement
Brand | Jul 2026 | Aug 2026 | Movement since baseline |
|---|---|---|---|
Abbott FreeStyle | 55.6% | 61.6% | Up 6.0 points |
Ascensia CONTOUR | 40.1% | 41.0% | Up 0.9 points |
LifeScan OneTouch | 10.9% | 11.5% | Up 0.6 points |
Prodigy Diabetes Care | 0.9% | 3.0% | Up 2.1 points |
Roche Accu-Chek | 28.5% | 31.0% | Up 2.5 points |
Trividia Health | 0.5% | 0.2% | Down 0.3 points |
Largest Increase: Prodigy Diabetes Care
Prodigy Diabetes Care more than tripled its valid recommendation coverage, rising to 3.0% in August 2026 from 0.9% in July 2026, a gain of 2.1 points that moved beyond normal month-to-month variation. The increase was driven by a rise in top-three placements, which grew to 2.5% in August 2026 from 0.2% in July 2026. The brand recorded only 12 valid recommendation appearances in August 2026, up from 4 in July 2026. Presence also rose to 3.6% in August 2026 from 1.8% in July 2026.
Category Leader: Abbott FreeStyle
Abbott FreeStyle held the top valid recommendation coverage in August 2026 at 61.6%, up from 55.6% in July 2026. The brand's rank-one rate eased to 9.7% from 10.4%, even as its coverage lead widened. Presence remained high at 95.2% in August 2026, slightly down from 96.8% in July 2026. The gap between Abbott FreeStyle and the second-place brand widened every month in the series.
Recommendation Placement Snapshot
Coverage alone does not show how prominently a brand is recommended. The leading brands show different patterns in first-position placement. Abbott FreeStyle led top-three rate at 53.2% in August 2026, while Ascensia CONTOUR led rank-one rate at 28.5% and posted a top-three rate of 37.1%.
Want the full Authority Index
The paid deep-dive adds competitor threat profiles, the gap matrix, citation failure map, platform-by-platform recovery roadmap, and client-specific economic modeling.
Brand | Aug 2026 top-three rate | Aug 2026 rank-one rate | Jul 2026 top-three rate | Jul 2026 rank-one rate |
|---|---|---|---|---|
Abbott FreeStyle | 53.2% | 9.7% | 51.8% | 10.4% |
Ascensia CONTOUR | 37.1% | 28.5% | 39.1% | 28.0% |
Roche Accu-Chek | 24.2% | 2.5% | 20.8% | 1.2% |
Close coverage can still hide different first-position rates: Abbott FreeStyle appeared in the top three more often than Ascensia CONTOUR in August 2026, yet Ascensia CONTOUR was the first recommendation more than twice as often.
Buyer-Intent Distribution
All qualified observations in both months fell into the Brand Recommendation class, which covers discovery and consideration queries.
Buyer-intent class | Jul 2026 | Aug 2026 |
|---|---|---|
Brand Recommendation | 432 | 393 |
Pricing & Value | 0 | 0 |
Multi-Brand Comparison | 0 | 0 |
Total qualified observations | 432 | 393 |
The current public series measures the Brand Recommendation class of discovery and does not yet contain qualified observations in the Pricing & Value or Multi-Brand Comparison classes.
Historical Measurement Record
This is an evergreen benchmark URL. New measurements are added to the same report.
Measurement | Qualified observations | Coverage leader | Leader coverage | Largest coverage movement |
|---|---|---|---|---|
Jul 2026 | 432 | Abbott FreeStyle | 55.6% | Abbott FreeStyle up 6.0 points (Jul to Aug) |
Aug 2026 | 393 | Abbott FreeStyle | 61.6% | Prodigy Diabetes Care up 2.1 points |
Evidence and Source Layer
The benchmark is built from prompt-level observations that retain the query, AI/search surface, answer, brand outcome, recommendation placement, sentiment, and, where exposed, citations or attributable evidence sources. Source presence is evidence about the information environment. It is not automatically proof that the source caused the recommendation.
Scope Boundaries
This public benchmark does not measure market share, attributable sales, every possible AI response, organic-search ranking, social mention volume, private or sponsored channels, or causality from a metric movement alone.
About This Benchmark
The LLM Authority Index AI Market Discovery Index tracks how AI search and chat surfaces discover, mention, and recommend brands within a vertical. The Healthcare and Medical Devices index covers six tracked brands across six canonical AI/search surface families, measuring presence, recommendation coverage, placement, and sentiment on a monthly basis.
- AI Market Discovery Index
- AI Market Discovery Methodology
- AI Market Discovery Metric Definitions
- AI Market Discovery Research Standards
- Modeled AI Authority Value
Get a Company-Level Authority Index
The public industry benchmark shows category-level standings. A company-level Authority Index can go deeper.
Want the full Authority Index
The paid deep-dive adds competitor threat profiles, the gap matrix, citation failure map, platform-by-platform recovery roadmap, and client-specific economic modeling.
Keep reading
Related posts
Industry Reports
Medical Billing Services: AI Market Discovery Index
Read this blog on LLM Authority Index.
ReadIndustry Reports
Medical Spas: AI Market Discovery Index
Read this blog on LLM Authority Index.
ReadIndustry Reports
Medical Evacuation: AI Market Discovery Index
Read this blog on LLM Authority Index.
Read